Detecting Alzheimer’s Disease: Older Adults’ Experiences with Cognitive Screening & Blood Biomarker Testing

The Institute for Healthcare Policy and Innovation at the University of Michigan recently published a study titled "Detecting Alzheimer’s Disease: Older Adults’ Experiences with Cognitive Screening & Blood Biomarker Testing." The article presents findings from a national survey conducted in January 2023, which explores the knowledge, utilization, and perceptions of cognitive screening and blood biomarker testing for Alzheimer's disease among adults aged 65-80. The study highlights the participants' views on the benefits, limitations, and potential risks associated with these screening methods and offers valuable insights for healthcare professionals and policymakers in the context of early detection and care planning for Alzheimer's disease